Bleeding and Thrombosis Following Initiation of Antithrombotic Therapy for Iliac Vein Stenting

Journal of Vascular Surgery Venous and Lymphatic Disorders 2026 Open access

Read full text
Authors: Shreef Said, Cayetana Lazcano-Etchebarne, Emily Gu, Kurt S. Schultz, Juan Carlos Perez Lozada, Hamid R. Mojibian, Robert Attaran, Cassius Iyad Ochoa Chaar
DOI: 10.1016/j.jvsv.2025.102386
Cited by: 0

Abstract

Antithrombotic therapy is routinely prescribed following iliac vein stenting (IVS) with significant variations in type and duration. In the absence of prospective trials, the risks and benefits of different regimens remain elusive. This study aimed to evaluate the long-term risks of bleeding, venous thrombosis, and arterial thrombosis in patients undergoing IVS for nonthrombotic iliac vein lesions (NIVL) compared with those treated for post-thrombotic syndrome (PTS).

Fields of Study & Subjects

Venous Thromboembolism Diagnosis and Management Peripheral Artery Disease Management Blood Coagulation and Thrombosis Mechanisms

Publication details

Journal / source
Journal of Vascular Surgery Venous and Lymphatic Disorders
Volume
14
Issue
2
Pages
102386–102386
Publication date
28 February 2026
Language
EN